We used quantitative real-time RT–PCR (qRT–PCR) to quantify the heterogeneity of fecal RPS27L levels in intermediate-stage CRC patients, and the differential expression of RPS27L was correlated with their clinical outcomes. Here, RPS27L is linked to colorectal carcinoma.